New hires and promotions in the med-tech industry, including: Current Health, Eitan Group, Laboratory for Advanced Medicine, Mevion Medical Systems, Mmi, Proscia.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agile, Alx, Arrevus, Ascletis, Biocryst, Glaxosmithkline, Horizon, Jazz, Monopar, Novartis, Pharmamar, Roche.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Aravive, Axim, Azurrx, Bellerophon, Bioxcel, BMS, Eisai, Five Prime, Foamix, Mirati, Moleculin, Mustang, Ra, Recardio, Reneo, Sensorion.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acucela, Astellas, Celltrion Healthcare, Kubota, Noxopharm, Pfizer, Seattle Genetics, Takeda, TLC Co.